Saudi KSrelief Inks Deal to Treat Gaza Cancer Patients

Amman, Jordan — Advisor at the Royal Court and Supervisor General of the King Salman Humanitarian Aid and Relief Center (KSrelief), Dr. Abdullah bin Abdulaziz Al Rabeeah, visited the King Hussein Cancer Center (KHCC) in Amman, Jordan, where he signed a joint agreement to treat 150 cancer patients from Gaza. The agreement, valued at $3,615,800, underscores Saudi Arabia’s continued humanitarian commitment to alleviating the suffering of cancer patients in the region.

Context and Background

The visit, which took place on July 4, 2024, was accompanied by Princess Ghida Talal, Chairperson of the KHCC Board of Trustees, and Naif bin Bandar Al-Sudairi, Saudi Ambassador to Jordan and non-resident Ambassador-designate to the State of Palestine. Dr. Al Rabeeah toured the KHCC’s departments to learn about medical cases and the center’s latest technical and medical specifications. He also gained insight into the level of cancer care in Jordan, including treatment, prevention, and awareness services provided to patients in Jordan and the Arab world.

The King Hussein Cancer Center is a renowned institution in the region, known for its comprehensive cancer care and advanced medical facilities. The agreement signed between KSrelief and KHCC represents a significant step in providing critical treatment to Palestinian cancer patients from the Gaza Strip, who face substantial challenges in accessing adequate healthcare.

Key Details of the Agreement

The joint agreement aims to provide treatment for 150 individuals from Gaza, with a total cost of $3,615,800. Princess Ghida Talal expressed her gratitude for the agreement, emphasizing the real chance it provides for Palestinian cancer patients from the Gaza Strip to recover. She thanked the Kingdom of Saudi Arabia, represented by KSrelief, for its continuous support for those in need worldwide.

Dr. Al Rabeeah noted that this agreement confirms the Kingdom’s commitment, through KSrelief, to provide support to cancer patients worldwide and alleviate their suffering. He expressed his gratitude to the government of Jordan for the facilities provided to the center, enabling its humanitarian work to be performed effectively.

Implications and Impact

This agreement highlights Saudi Arabia’s ongoing humanitarian efforts in the region and beyond. By partnering with the King Hussein Cancer Center, KSrelief ensures that Palestinian patients receive world-class cancer treatment in a specialized facility. The initiative not only provides immediate medical relief but also strengthens the bonds between Saudi Arabia, Jordan, and the Palestinian people.

The agreement is part of a broader trend of Saudi humanitarian assistance, which has consistently supported health initiatives in conflict-affected areas. The treatment of cancer patients from Gaza is particularly crucial given the ongoing challenges in the region’s healthcare infrastructure.

Vision 2030 Alignment

This humanitarian agreement aligns with Saudi Vision 2030’s emphasis on social responsibility and global engagement. Under the leadership of Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and His Royal Highness Crown Prince Mohammed bin Salman, Saudi Arabia continues to play a pivotal role in regional stability and humanitarian aid. KSrelief, as the Kingdom’s humanitarian arm, exemplifies Vision 2030’s goal of fostering international cooperation and improving quality of life for people in need.

20 Questions

Q1. Who signed the agreement to treat Gaza cancer patients in Jordan?

A1. Dr. Abdullah bin Abdulaziz Al Rabeeah, Supervisor General of KSrelief, and Princess Ghida Talal, Chairperson of the King Hussein Cancer Center Board of Trustees, signed the agreement.

Q2. How many patients will be treated under this agreement?

A2. The agreement aims to provide treatment for 150 individuals from Gaza.

Q3. What is the total cost of the agreement?

A3. The total cost of the agreement is $3,615,800.

Q4. Where was the agreement signed?

A4. The agreement was signed in Amman, Jordan, at the King Hussein Cancer Center.

Q5. Who accompanied Dr. Al Rabeeah during the visit?

A5. He was accompanied by Princess Ghida Talal and Naif bin Bandar Al-Sudairi, Saudi Ambassador to Jordan.

Q6. What is the King Hussein Cancer Center known for?

A6. It is a renowned institution in the region, known for its comprehensive cancer care and advanced medical facilities.

Q7. What did Dr. Al Rabeeah do during his visit?

A7. He toured the KHCC’s departments to learn about medical cases and the center’s latest technical and medical specifications.

Q8. What did Princess Ghida Talal say about the agreement?

A8. She expressed gratitude, emphasizing the real chance it provides for Palestinian cancer patients from Gaza to recover, and thanked Saudi Arabia for its continuous support.

Q9. What did Dr. Al Rabeeah note about the agreement?

A9. He noted that it confirms the Kingdom’s commitment, through KSrelief, to provide support to cancer patients worldwide and alleviate their suffering.

Q10. Whom did Dr. Al Rabeeah thank?

A10. He thanked the government of Jordan for the facilities provided to the center, enabling its humanitarian work to be performed effectively.

Q11. What is KSrelief?

A11. KSrelief is the King Salman Humanitarian Aid and Relief Center, Saudi Arabia’s humanitarian arm.

Q12. What does the agreement aim to achieve?

A12. It aims to provide treatment for 150 cancer patients from Gaza, offering them access to world-class cancer care.

Q13. When did the visit and signing take place?

A13. The visit and signing took place on July 4, 2024.

Q14. What is the significance of this agreement?

A14. It highlights Saudi Arabia’s ongoing humanitarian efforts and strengthens bonds between Saudi Arabia, Jordan, and the Palestinian people.

Q15. How does this agreement align with Saudi Vision 2030?

A15. It aligns with Vision 2030’s emphasis on social responsibility and global engagement, showcasing Saudi Arabia’s role in humanitarian aid.

Q16. What services does KHCC provide?

A16. KHCC provides treatment, prevention, and awareness services for cancer patients in Jordan and the Arab world.

Q17. Who is the Saudi Ambassador to Jordan?

A17. Naif bin Bandar Al-Sudairi is the Saudi Ambassador to Jordan and non-resident Ambassador-designate to the State of Palestine.

Q18. What did Dr. Al Rabeeah learn about cancer care in Jordan?

A18. He learned about the level of cancer care, including treatment, prevention, and awareness services provided to patients.

Q19. How does this agreement benefit Palestinian patients?

A19. It provides them with access to specialized cancer treatment in a renowned facility, offering a chance for recovery.

Q20. What is the broader impact of this initiative?

A20. It demonstrates Saudi Arabia’s commitment to humanitarian causes and contributes to regional health and stability.

---